Zobrazeno 1 - 10 of 266 pro vyhledávání: '"Shohreh, Shahabi"'
1
Akademický článek
Further content validation of the 18-item NCCN/FACT Ovarian Symptom Index and its Disease Related Symptom-Physical (DRS-P) subscale for use in advanced ovarian cancer clinical trials
Autor: Sara Shaunfield, Sally Jensen, Allison P. Fisher, Kimberly Webster, Shohreh Shahabi, Arijit Ganguli, David Cella
Publikováno v: Health and Quality of Life Outcomes, Vol 17, Iss 1, Pp 1-9 (2019)
Abstract Background This study evaluated pre-defined aspects of content validity of the 18-item NCCN FACT-Ovarian Symptom Index (NFOSI-18) and its Disease-Related Symptoms-Physical (DRS-P) subscale, as clinical trial outcome tools for patients with a
Externí odkaz: https://doaj.org/article/37d4f72a01f24da08e4259d93dab3f9d
Zobrazit plný text záznamu
4
Data from 21-Gene Recurrence Score Assay Predicts Benefit of Post-Mastectomy Radiotherapy in T1-2 N1 Breast Cancer
Autor: Jonathan B. Strauss, Shohreh Shahabi, Eric D. Donnelly, Masha Kocherginsky, Brandon-Luke L. Seagle, Chelain R. Goodman
Purpose: Post-mastectomy radiotherapy (PMRT) yields improvements in both locoregional control and overall survival (OS) for women with T1-2 N1 breast cancer. The value of PMRT in this population has been questioned given advances in systemic therapy.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::033773e8297180868183f5718c78c43a
https://doi.org/10.1158/1078-0432.c.6529008.v1
Zobrazit plný text záznamu
6
Supplementary Figure 3 from Gender Influences the Class III and V β-Tubulin Ability to Predict Poor Outcome in Colorectal Cancer
Autor: Cristiano Ferlini, Shohreh Shahabi, Giovanni Scambia, Claudio Coco, Enrica Martinelli, Candice Martino, Steven Sieber, Stefano Sioletic, Gian Franco Zannoni, Marisa Mariani
PDF file, 67KB, Line chart showing the gene expression values for the cell lines at the baseline and upon serum starvation. On the left and right male and female cell lines are represented, respectively. On the top and bottom results for TUBB3 and TU
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7b1627e3118f24ca34341199040c105
https://doi.org/10.1158/1078-0432.22444634.v1
Zobrazit plný text záznamu
7
Data from Gender Influences the Class III and V β-Tubulin Ability to Predict Poor Outcome in Colorectal Cancer
Autor: Cristiano Ferlini, Shohreh Shahabi, Giovanni Scambia, Claudio Coco, Enrica Martinelli, Candice Martino, Steven Sieber, Stefano Sioletic, Gian Franco Zannoni, Marisa Mariani
Purpose: Colorectal cancer is one of the deadliest diseases in Western countries. To predict the outcome of therapy, we assessed the role of class III (TUBB3) and class V β-tubulin (TUBB6) as predictive biomarkers.Experimental Design: Using immunohi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd01b2467f3e84e0e454a99fc6e17311
https://doi.org/10.1158/1078-0432.c.6520247.v1
Zobrazit plný text záznamu
9
Figure S1. Adjusted survival curves for the matched NCDB and SEER cohorts. from 21-Gene Recurrence Score Assay Predicts Benefit of Post-Mastectomy Radiotherapy in T1-2 N1 Breast Cancer
Autor: Jonathan B. Strauss, Shohreh Shahabi, Eric D. Donnelly, Masha Kocherginsky, Brandon-Luke L. Seagle, Chelain R. Goodman
Adjusted survival curves based on Kaplan-Meier estimates of overall survival for women within the matched cohorts of the Low-, Intermediate-, and High-Risk 21-gene Recurrence Score Assay diagnosed with T1-2 N1 ER-positive breast cancer treated with (
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14918007b7974813db803a7c059883a1
https://doi.org/10.1158/1078-0432.22475166.v1
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje